BUDAPEST — Repetitive transcranial magnetic stimulation (rTMS) can be useful treatment for some people with major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), but its use is only ...
The FDA has expanded clearance for an accelerated treatment protocol for the noninvasive Deep Transcranial Magnetic Stimulation (Deep TMS, BrainsWay) system for depressive episodes and anxiety ...
Major depressive disorder (MDD) is a debilitating illness that includes depressive mood. Repetitive Transcranial Magnetic Stimulation (rTMS) is a therapy method used in the treatment of MDD. The ...
BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
BURLINGTON, Mass. and JERUSALEM, June 11, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders ...
Because of rising rates of anxiety, depression and other mental health concerns among adolescents, TMS has been used off-label for many years to treat depression among teenagers The US Centers for ...
Medicare covers transcranial magnetic stimulation (TMS) as a treatment for severe major depressive disorder (MDD) if it is deemed medically necessary, but coverage is limited to a maximum of 6 weeks.
Major depressive disorder (MDD) is one of the leading causes of poor health and disability worldwide [1]. Despite its pervasiveness, its heterogeneous presentation [2] has made it difficult to ...
Please provide your email address to receive an email when new articles are posted on . The Apollo TMS device was previously FDA cleared for treating MDD in adults. TMS offers a non-pharmacologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results